cumulate in lung tissue and airspaces in both GM-CSF (5)-and SP-D-deficient (3, 13) mice. Whether SP-D and GM-CSF regulate distinct or shared pathways to regulate surfactant homeostasis is unknown.
SP-D is a member of the collectin family of calciumdependent lectins (4) . Although SP-D binds relatively weakly to surfactant phospholipids, null mutations in the SP-D gene [SP-D(Ϫ/Ϫ)] caused marked increases in tissue and alveolar surfactant saturated phosphatidylcholine (Sat PC) in vivo (3, 13) . A number of distinct changes in surfactant homeostasis are characteristic of SP-D(Ϫ/Ϫ) mice, including increased surfactant phospholipids, markedly decreased SP-A and SP-C relative to Sat PC, rapid conversion from large-aggregate to small-aggregate surfactant forms, and decreased catabolism of endogenously synthesized Sat PC (11) . Inactivation of the SP-D gene in mice also caused emphysema and increased numbers of lipid-laden, foamy alveolar macrophages (22) . Surfactant abnormalities were corrected by genetic replacement of SP-D in the respiratory epithelium of the SP-D(Ϫ/Ϫ) mice (6) . Thus SP-D deficiency caused abnormalities in lung structure and surfactant metabolism.
Targeted disruption of the GM-CSF gene (5, 10) or the GM-CSF receptor common ␤-chain genes in mice (18, 20) caused pulmonary alveolar proteinosis associated with a marked increase in tissue and alveolar Sat PC pool sizes. The increase in surfactant phospholipids associated with deficiencies in GM-CSF signaling were similar in extent to those observed in the SP-D(Ϫ/Ϫ) mice. However, unlike the SP-D(Ϫ/Ϫ) mice, SPs were also markedly increased in the GM-CSF or GM-CSF receptor ␤-chain-deficient mice (20) . In contrast to findings in SP-D(Ϫ/Ϫ) mice, catabolism of both surfactant lipid and proteins by alveolar macrophages was markedly decreased in the absence of GM-CSF signaling in vitro (24) and in vivo (10) . Local replacement of GM-CSF in lungs of GM-CSF-deficient [GM(Ϫ/Ϫ)] mice corrected alveolar proteinosis (9, 19) and host defense abnormalities typical of GM-CSF deficiency (15) .
Although both genes are important determinants of surfactant phospholipid homeostasis, the precise mechanisms by which GM-CSF and SP-D influence surfactant pools remain unclear. The present studies were undertaken to identify potential relationships or interactions between GM-CSF-and SP-D-dependent pathways in the regulation of surfactant homeostasis. Surfactant metabolism was studied in SP-D and GM-CSF null mutant [SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ)] mice and SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ) mice in which GM-CSF expression was increased in the respiratory epithelium by using SP-C as a promoter [SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ),SP-C/GM(ϩ/ ϩ) mice]. Data presented support the concept that SP-D and GM-CSF regulate surfactant phospholipid homeostasis by distinct mechanisms.
METHODS
Mice. Generation of SP-D(Ϫ/Ϫ) (13), GM(Ϫ/Ϫ) (5), and GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) (8) mice has been described previously. GM(Ϫ/Ϫ) and SP-C/GM(ϩ/ϩ) mice were mated to produce heterozygous offspring that were mated to produce GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) mice in the C57BL/6 background. GM-CSF is selectively expressed in the lungs of SP-C/ GM(ϩ/ϩ) mice and absent from other tissues in the GM(Ϫ/Ϫ) background. Subsequent matings produced litters of mice with the SP-C/GM(ϩ/ϩ) genotype, confirming homozygosity of the offspring. These mice were mated to SP-D(Ϫ/Ϫ) mice, the latter in the Black Swiss background. Siblings were mated through at least three generations to produce doubleknockout mice [SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ)] that were also heterozygous or homozygous for the SP-C/GM transgene. Comparisons were made among control mice (wild type) that were F 2 littermates of Black Swiss C57BL/6 crosses and compared with identical crosses between SP-D(Ϫ/Ϫ)/Black Swiss and GM(Ϫ/Ϫ)/C57BL/6 mice to control for potential strain-dependent influences. Genotyping was performed on tail DNA by PCR and/or Southern blot analysis as previously described (5, 8, 13) .
All of the studies were performed with 7-to 9-wk-old mice. Mice were maintained in cages containing high-efficiency particulate-filtered air in a barrier facility. There was no evidence of pathogens in sentinel mice comaintained in the vivarium. All procedures were conducted under Institutional Animal Care and Use Committee-approved methods.
Sat PC pool size. Sat PC pools (calculated as mol/kg body wt) were measured in alveolar lavage fluid and lung tissue after alveolar lavage as previously described (11) in 22 wildtype mice; 40 SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ) mice; and 36 SP-D(Ϫ/ Ϫ),GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) mice. Each mouse was deeply anesthetized with intraperitoneal pentobarbital sodium, and the distal aorta was cut to exsanguinate the animal. After the chest was opened, a 20-gauge blunt needle was tied to the trachea, and 0.9% NaCl at 4°C was flushed in the airway until the lungs were fully expanded. The fluid was withdrawn by syringe three times for each aliquot. The saline lavage was repeated five times, and the samples were pooled. The lavaged lung tissue was homogenized in 0.9% NaCl. Aliquots of alveolar lavage fluid and the lung homogenates were extracted with chloroform-methanol (2:1; see Ref.
2), and Sat PC was isolated with the technique of Mason et al. (16) . The amount of Sat PC was measured by phosphorus assay (1) .
SP-A content. The SP-A in alveolar lavage fluid was analyzed by Western blot in six mice from each genotype (11, 20) . Samples containing 1 g of Sat PC were used for analyses of SP-A. Proteins were separated by SDS-PAGE in the presence of ␤-mercaptoethanol. After electrophoresis, SP-A was transferred to nitrocellulose paper (Schleicher and Schnell, Keene, NH), and immunoblot analysis was carried out with dilution of 1:5,000 guinea pig anti-mouse SP-A. Appropriate peroxidase-conjugated secondary antibodies were used at 1:5,000 dilutions. Immunoreactive bands were detected with enhanced chemiluminescence reagents (Amersham, Chicago, IL). Protein bands were quantitated by densitometric analyses with Alpha Imager 2000 documentation and analysis software (Alpha Innotech, San Leandro, CA). Linearity of the assay was confirmed for the range of 10 -200 ng of mouse SP-A (R 2 ϭ 0.95). Clearance of dipalmitoylphosphatidylcholine. Eight mice from each group were anesthetized with methoxyflurane and orally intubated with a 25-gauge animal-feeding needle. Each mouse received 60 l of saline containing 0.5 Ci of [ 3 H]choline-labeled dipalmitoylphosphatidylcholine (DPPC; American Radiolabeled Chemicals, St. Louis, MO), 1.5 g of DPPC, and 3.3 g of lipid-extracted mouse surfactant suspended by the use of glass beads (11) . The phospholipids given by intratracheal injection were 2% of the alveolar pool size for wild-type mice. After injection (40 h), mice were killed. Radioactivity was then measured in Sat PC isolated from alveolar lavage fluid and lung homogenate.
Precursor incorporation in Sat PC. Mice were given intraperitoneal injections of 10 l saline/g body wt containing 0.5 Ci [
3 H]palmitic acid/g body wt (American Radiolabeled Chemicals; see Ref. 10) . The palmitic acid was stabilized in solution with 5% human serum albumin. Groups of eight mice were killed at 2, 16, and 48 h after precursor injection, and alveolar lavage fluid was recovered from each animal. Lung tissue was homogenized in 0.9% NaCl. Sat PC was isolated from alveolar lavage fluids and lung homogenates as described for Sat PC pool sizes, and radioactivity was measured.
DPPC degradation by alveolar macrophage. Alveolar macrophages were isolated from the alveolar lavage fluid, and the degradation of radiolabeled DPPC was studied as described previously (24) . Alveolar macrophages from wild-type mice, SP-D(Ϫ/Ϫ) mice, SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ) mice, and SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) mice were studied. Alveolar lavage was performed with PBS containing 0.5 mM EDTA. Lavage fluid was centrifuged at 1,000 g for 5 min. Recovered cells were then resuspended in DMEM containing 0.1% BSA and were cultured at a density of 1 ϫ 10 5 cells/well in flat-bottom, 96-well tissue culture plates. Cells were allowed to adhere for 1 h at 37°C. Nonadherent cells were removed, and the adherent alveolar macrophages were washed three times with DMEM containing 0.1% BSA. With this method, Ͼ90% of cells recovered were macrophages.
To assess DPPC degradation, natural surfactant isolated from normal mouse lung lavage fluid was labeled by mixing
Amersham, Arlington Heights, IL). The labeled surfactant was resuspended in medium containing 100 g/ml phospholipid with 10 Ci/ml [ 3 H]DPPC. To determine degradation of [ 3 H]DPPC, cells were incubated for 5 h at 37°C with the [ 3 H]DPPC-labeled surfactant in culture medium. After incubation, the supernatant was collected, and the cells were lysed with lysis buffer [50 mM Tris ⅐ HCl (pH 8), 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.1% sodium deoxycholate, and 5 mM EDTA]. The lipid and aqueous fractions were extracted from both supernatants and cells according to Bligh and Dyer (2) . The degradation of [ 3 H]DPPC by alveolar macrophages was estimated by measuring the generation of radioactive products partitioning in the water-methanol phase during the extraction. Background radioactivity in the absence of the cells was subtracted.
Lung histology. Lungs from each genotype (n ϭ 2/genotype) were inflation fixed at 25 cmH 2O with 4% paraformaldehyde. Tissue was embedded in paraffin, sectioned, and stained with hematoxylin and eosin.
Data analysis. All values are given as means Ϯ SE. The between-group comparisons were made by ANOVA followed by the Student-Newman-Keuls multiple-comparison procedure.
RESULTS
Sat PC and SP-A pool size. Surfactant Sat PC (mol/ kg) was determined in alveolar lavage fluid, lung tissue after lavage, and total lung (lavage fluid ϩ tissue; Fig.  1A ). Relative changes in Sat PC were compared with wild-type mice, which were given the value of one (Fig.  1B) . Total surfactant Sat PC was 14.5-fold higher in SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ) mice than in wild-type mice and was considerably higher than the Sat PC in either GM(Ϫ/Ϫ) or SP-D(Ϫ/Ϫ) mice previously reported (10, 11) . Thus the increases in Sat PC pools in the SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ) mice were approximately additive. Repletion of GM-CSF in the SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ) double-knockout mice with the SP-C/GM(ϩ/ϩ) transgene substantially decreased the Sat PC pool size in total lung and lavage fluid to levels consistent with that of the SP-D(Ϫ/Ϫ) mice (11) . Thus local expression of GM-CSF in the lung partially corrected the defect in the GM(Ϫ/Ϫ),SP-D(Ϫ/Ϫ) mice to that typical of SP-D(Ϫ/Ϫ) mice. Comparisons were made among littermates derived from F 2 crosses between Black Swiss and C57BL/6 to control for potential strain differences. Thus combined deficiency of both GM-CSF and SP-D resulted in increased Sat PC pools, consistent with an approximately additive effect of each gene on surfactant pool size. These results demonstrated that expression of GM-CSF in the lung restored surfactant homeostasis related to GM-CSF deficiency but did not correct SP-D-dependent differences.
SP pool sizes. The content of alveolar SP-A relative to Sat PC was estimated by Western blot analysis and normalized to the quantity of SP-A in wild-type mice, which were given the value of one. The concentration of SP-A in both SP-D(Ϫ/Ϫ) and GM(Ϫ/Ϫ) mice relative to the wild type was also included for comparison ( Precursor incorporation. Mice were given weightadjusted doses of [ 3 H]palmitic acid to measure net incorporation in Sat PC at 2 h, secretion of the labeled Sat PC to the alveoli at 16 h, and loss of labeled Sat PC from the lung 48 h after precursor injection (Fig. 4) . After injection (2 h), no significant differences in initial incorporation were observed among the three groups of mice. Likewise, percent secretion in alveolar lavage fluid, calculated at 16 h as percent of total lung incorporation, was similar in all groups of mice as follows: 32 Ϯ 2% in wild-type, 29 Ϯ 4% in SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ), and 27 Ϯ 6% in SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) mice. At 48 h after injection, labeled Sat PC was similar and significantly higher in SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ) and SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) mice compared with wild-type mice, consistent with the increased precursor incorporation seen at later times after precursor injection typical of SP-D(Ϫ/Ϫ) mice, as previously described (11) .
DPPC degradation by alveolar macrophages. In vitro surfactant catabolism by alveolar macrophages from SP-D(Ϫ/Ϫ) and SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) mice was similar to that from wild-type mice (Fig. 5) . The marked decrease in [ 3 H]DPPC catabolism by alveolar macrophages from GM(Ϫ/Ϫ) mice was demonstrated previously ( The precise mechanisms by which surfactant homeostasis is maintained in normal lung remain unknown. Surfactant lipids are synthesized, catabolized, or recycled (12) by type II epithelial cells. Alveolar macrophages play an important role in surfactant catabolism (21) . Precise contribution of the respiratory epithelium and alveolar macrophages in catabolism of surfactant remains unclear. Recent studies in the mouse suggest that ϳ50% of DPPC is catabolized by alveolar-and tissue-associated macrophages, and ϳ50% is catabolized by type II epithelial cells (7) . Deficits in surfactant catabolism account for the increased surfactant pool sizes characteristic of GM(Ϫ/Ϫ) mice (10, 20, 24) . In contrast, tissue and alveolar pool sizes are increased in SP-D(Ϫ/Ϫ) mice without associated abnormalities in surfactant clearance (11) .
Multiple abnormalities in surfactant structure and surfactant homeostasis were caused by targeted disruption of the mouse SP-D gene. However, the mechanisms by which lung surfactant homeostasis is altered in SP-D(Ϫ/Ϫ) mice are complex and not related to defects in surfactant lipid clearance. Although the increases in surfactant pool sizes are similar in both GM(Ϫ/Ϫ) and SP-D(Ϫ/Ϫ) mice, clearance of surfactant by the alveolar macrophage is deficient in GM(Ϫ/Ϫ) but not in SP-D(Ϫ/Ϫ) mice. Foamy macrophages accumulate in the lungs of SP-D(Ϫ/Ϫ) mice; however, the present in vitro studies demonstrate that alveolar macrophages from SP-D(Ϫ/Ϫ) mice degrade phospholipids normally. Increasing the surfactant pool size by exogenous surfactant also induces a transient foamy macrophage population but does not alter surfactant catabolism in mice (14) . Thus the abnormalities in surfactant homeostasis seen in SP-D(Ϫ/Ϫ) mice do not Sat PC continued to accumulate in alveolar lavage fluid in SP-D(Ϫ/Ϫ),GM(Ϫ/Ϫ),SP-C/GM(ϩ/ϩ) and SP-D(Ϫ/Ϫ) mice, consistent with altered surfactant pools seen previously in SP-D(Ϫ/Ϫ) mice (11) . In the present study, we compared surfactant metabolism under identical experimental conditions in mice with distinct genotypes. However, the methodology used to estimate surfactant metabolism requires a number of assumptions, such as similar Sat PC precursor pools in all genotypes. The times chosen for kinetic studies were based on our previous studies of Sat PC synthesis secretion and clearance but are not complete enough to accurately determine turnover time of Sat PC. Likewise, we assumed that catabolism of DPPC in the lung was minimal and that labeled DPPC was uniformly distributed in the alveoli after intratracheal administration.
In vitro degradation of DPPC by alveolar macrophages isolated from GM(Ϫ/Ϫ) mice was slow and was not influenced by the lack of SP-D. Thus effects of GM-CSF on surfactant homeostasis are related primarily to its effects on surfactant catabolism dependent on alveolar macrophage function and are independent of SP-D. The altered surfactant homeostasis seen in SP-D(Ϫ/Ϫ) mice is not directly related to surfactant catabolism by the alveolar macrophage but is probably related to changes in surfactant metabolism by type II epithelial cells and the altered surfactant Sat PC pool in both alveolar and cellular components of the lung. Effects of SP-D deficiency are not mediated primarily by effects on surfactant catabolism by alveolar macrophages and were mediated relatively independently of GM-CSF.
